samarium has been researched along with Bone Cancer in 107 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (9.35) | 18.7374 |
1990's | 38 (35.51) | 18.2507 |
2000's | 40 (37.38) | 29.6817 |
2010's | 18 (16.82) | 24.3611 |
2020's | 1 (0.93) | 2.80 |
Authors | Studies |
---|---|
Chindarkar, AS; Dey, AC; Kulkani, MS; Mishra, SG; Sanjeev Kumar, B; Sawant, DK; Thamke, AN | 1 |
Alonso-Coello, P; Martinez-Zapata, MJ; Roqué I Figuls, M; Scott-Brown, M | 2 |
Kolesnikov-Gauthier, H; Lemoine, N; Olivier, A; Oudoux, A; Penel, N; Tresch-Bruneel, E | 1 |
Chakraborty, S; Chakravarty, R; Dash, A; Khan, MS; Ram, R; Sarma, HD | 1 |
Aktolun, C; Bodei, L; Delgado-Bolton, RC; Ezziddin, S; Gabriel, M; Giammarile, F; Handkiewicz-Junak, D; Poeppel, TD | 1 |
Colasurdo, AP; Gallicchio, R; Guglielmi, G; Landriscina, M; Mainenti, PP; Mastrangelo, PA; Nardelli, A; Storto, G | 1 |
Campos, TP; Dalmázio, I; Donanzam, BA; Valente, ES | 1 |
Gallicchio, R; Gattozzi, D; Giacomobono, S; Maddalena, F; Mainenti, P; Nardelli, A; Pellegrino, T; Simeon, V; Storto, G | 1 |
Guerra Liberal, FD; Tavares, AA; Tavares, JM | 1 |
Guerra Liberal, FDC; Tavares, AAS; Tavares, JMRS | 1 |
Lutz, S; Simone, CB; Wei, RL | 1 |
de Klerk, JM; Hoekstra, A; Lam, MG; van Rijk, PP; Zonnenberg, BA | 1 |
Berent, LM; Bommarito, D; Bryan, JN; Bryan, ME; Cutler, C; Engelbrecht, H; Henry, CJ; Ketring, A; Kim, DY; Lattimer, JC | 1 |
Li, W; Pei, FX; Shen, B; Yang, J; Zeng, JC | 1 |
Bourre, JC; Caravel, JP; Desruet, MD; Skalli, S; Vuillez, JP | 1 |
Hiltunen, J; Sinzinger, H; Weiss, K | 1 |
Abrahamsen, J; Jakobsen, M; Jønler, M; Lund, L; Petersen, LJ | 1 |
Flux, GD; Hindorf, C; Ibisch, C; Kraeber Bodéré, F | 1 |
Bączyk, M | 1 |
O'Sullivan, JM; Parker, CC; Vengalil, S | 1 |
Morgans, AK; Smith, MR | 1 |
D'angelo, G; Maini, CL; Mantini, G; Mariani, G; Salvatori, M; Sciuto, R; Sperduti, I | 1 |
Antczak, A; Baczyk, M; Gut, P; Hrab, M; Milecki, P; Pisarek, M | 1 |
Douard, MC; George, B; Rain, JD | 1 |
Lass, P; Scheffler, J | 1 |
Cermáková, E; Dolezal, J; Vizd'a, J | 1 |
Fuster, D; Pons, F; Vidal-Sicart, S | 1 |
Coleman, RE; Ell, PJ; Freeman, LM; Hoskin, PJ; Kotler, JA; Olivier, P; Quick, DP; Reid, RH; Sartor, O | 1 |
Szefer, J; Zuchora, Z | 1 |
Bataillard, A; Breteau, N; Carrie, C; Claude, L; Dijoud, F; Gentet, JC; Giammarile, F; Jouve, JL; Kind, M; Marec-Bérard, P; Mascard, E; Philip, T; Rousmans, S | 1 |
Finlay, IG; Mason, MD; Shelley, M | 1 |
Antoñanzas Villar, F; Carreras Coderch, L; Coya Viña, J; Echevarría Icaza, A; Martín Comín, J; Martínez Carderón, F; Nieto Martín-Bejarano, J; Sáenz Cusí, A; Serrano Bermúdez, G; Velasco Latrás, M | 1 |
Albritton, K; Anderson, PM; Dubansky, SA; Erlandson, L; Rodriguez, V; Trotz, B; Wiseman, GA | 1 |
Anderson, P | 1 |
Chen, LX; Fan, W; Liu, XW; Tang, Q; Wang, GH; Zeng, ZY; Zhi, SF | 1 |
Chen, LX; Fan, W; Gan, F; Liu, XW; Tang, Q; You, RA; Zhang, WG | 1 |
Bushnell, DL; Ell, PJ; Quick, DP; Reid, RH; Sartor, O | 1 |
Dolezal, J; Odrazka, K; Vizda, J | 1 |
Franklin, S; Hillegonds, DJ; Shelton, DK; Vijayakumar, S; Vijayakumar, V | 1 |
Anderson, P; Nuñez, R | 1 |
Dahmane, A; de Klerk, JM; Lam, MG; Stevens, WH; van Rijk, PP; Zonnenberg, BA | 1 |
Bushnell, D; Higano, CS; Quick, DP; Sartor, O | 1 |
Linzner, U; Müller, WA; Scháffer, EH | 1 |
Deng, H; Hu, Y; Kuan, A; Mo, T; Tan, T; Zhong, S | 1 |
Bayouth, JE; Fossella, FV; Kasi, LP; Macey, DJ | 1 |
Jiang, CY; Zhang, YJ; Zhu, BL | 1 |
Ahonen, A; Hannelin, M; Heikkilä, J; Hiltunen, J; Jakobsson, M; Joensuu, H; Jurvelin, J; Kairemo, K; Kulmala, J; Kumpulainen, E | 1 |
McEwan, AJ | 1 |
Lewington, VJ | 2 |
Holmes, RA | 1 |
Addison, SJ; Appelbaum, F; Baker, M; Collins, C; Eary, JF; Ferency, S; Hartnett, S; Petersdorf, S; Stabin, M; Vernon, C | 1 |
Fodstad, O; Kjønniksen, I; Winderen, M | 1 |
Ben-Josef, E; Davis, L; Porter, AT | 1 |
Appelbaum, FR; Bush, NE; Chapman, CR; Collins, C; Donaldson, G; Eary, JF; Gordon, EE; Livingston, RB; Petersdorf, S; Vernon, C | 1 |
Clarke, SE | 1 |
Fordyce, WA; Fossella, FV; Goeckeler, WF; Kasi, LP; Price, DR; Stoneburner, LK | 1 |
Deng, H; Hu, Y; Jiao, J; Liang, Z; Luo, S; Mo, T; Pu, M; Tan, T; Wang, Q; Zhong, S | 1 |
Charmaine de Witt, G; Hefter, G; May, PM; Webb, J | 1 |
Atkins, HL; Srivastava, SC | 1 |
Alberts, AS; Kritzinger, V; Louw, WK; Nel, JS; Smit, BJ; van Beek, A; van Rensburg, AJ | 1 |
Williams, JE | 1 |
Chatal, JF; Duchesne, G; Ell, P; Fauser, A; Fischer, M; Fogelman, I; Houston, S; Pecking, A; Resche, I; Rubens, R; Wilkins, D | 1 |
Bruland, OS; Hassfjell, SP; Hoff, P; Skretting, A | 1 |
Croft, S; Dormehl, I; Louw, WK; Milner, RJ | 1 |
Coleman, RE | 1 |
Alberts, AS; Louw, WK; van Rensburg, AJ | 1 |
Chuan, L; He, YJ; Hou, QT; Luan, ZS; Oyang, QH; Tian, JH; Wang, JM; Zhang, JM | 1 |
Cameron, PJ; Klemp, PF; Martindale, AA; Turner, JH | 1 |
Papatheofanis, FJ | 1 |
Aas, M; Bruland, OS; Gamlem, H; Moe, L; Ottesen, N; Skretting, A | 1 |
Bielack, S; Franzius, C; Jürgens, H; Schober, O; Sciuk, J; Vollet, B | 1 |
Krishnamurthy, GT; Krishnamurthy, S | 1 |
Serafini, AN | 3 |
Dickie, GJ; Macfarlane, D | 1 |
Fu, Z; Lei, XH; Shi, B | 1 |
Lopez, JG; Manel, A; Perrin, P; Perrin-Fayolle, O; Ruffion, A; Valignat, C | 1 |
Jackson, GE; Jarvis, NV; Louw, WK; Zeevaart, JR | 1 |
Baffa, O; Braga, FJ; Graeff, CF; Kinoshita, A | 1 |
Brenner, W; Henze, E; Kampen, AM; Kampen, WU | 1 |
Ford, PV; Murphy, PH | 1 |
Bruland, OS; Kvinnsland, Y; Skretting, A | 1 |
Bernà, L; Cunill, C; Javier Mateos, J; Martín, F; Nadal, C; Ortega, M; Pons, F | 1 |
Anderson, PM; Arndt, CA; Bruland, OS; Dispenzieri, A; Hartmann, LC; Mullan, BP; Smithson, WA; Wiseman, GA | 1 |
Chan, WL; Singh-Wadhwa, S; Verma, N | 1 |
Bielack, SS; Franzius, C; Schuck, A | 1 |
Bruland, O; Kvinnsland, Y; Moe, L; Skretting, A | 1 |
Atefie, K; Köck, HH; Sinzinger, H; Weiss, K | 1 |
György, T; János, T; Márton, F; Pál, NT; Zsigmond, K | 1 |
Curley, T; Larson, S; O'Moore, PV; Scher, HI; Tong, W; Yeh, S | 1 |
Budd, RS; Martin, JJ; Sandeman, TF | 1 |
Corwin, LA; Ehrhardt, GJ; Goeckeler, WF; Hewett, JE; Ketring, AR; Lattimer, JC; Simon, J; Stapleton, J; Volkert, WA | 1 |
Willett, CG | 1 |
Anderson, SK; Corwin, LA; Ehrhardt, GJ; Goeckeler, WF; Ketring, AR; Lattimer, JC; Simon, J; Stapleton, J; Volkert, WA | 1 |
Burckhardt, P; Leyvraz, S | 1 |
Farhangi, M; Holmes, RA; Ketring, AR; Singh, A; Stringham, LM; Volkert, WA; Williams, A | 1 |
Claringbold, PG; Fleay, RF; Hetherington, EL; Hoffman, RF; Martindale, AA; Sorby, P; Turner, JH | 1 |
Claringbold, PG; Hetherington, EL; Martindale, AA; Sorby, P; Turner, JH | 1 |
Ketring, AR | 1 |
Holmes, RA; Logan, KW; Volkert, WA | 1 |
Edwards, B; Goeckeler, WF; Simon, J; Troutner, DE; Volkert, WA; Wilson, D | 1 |
O'Mara, RE; Subramanian, G | 1 |
Blair, RJ; Greene, MW; Lebowitz, E; McAfee, JG; O'Mara, RE; Subramanian, G | 1 |
28 review(s) available for samarium and Bone Cancer
Article | Year |
---|---|
WITHDRAWN: Radioisotopes for metastatic bone pain.
Topics: Bone Neoplasms; Fractures, Bone; Humans; Hypercalcemia; Pain; Pain Measurement; Phosphorus Radioisotopes; Radioisotopes; Randomized Controlled Trials as Topic; Ruthenium Radioisotopes; Samarium; Spinal Cord Compression; Strontium Radioisotopes | 2017 |
Radium-223 for the treatment of bone metastases in castration-resistant prostate cancer: when and why.
Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radium; Samarium; Strontium Radioisotopes | 2019 |
Palliative treatment of metastatic bone pain with radiopharmaceuticals: A perspective beyond Strontium-89 and Samarium-153.
Topics: Bone Neoplasms; Female; Humans; Male; Pain Management; Palliative Care; Radioisotopes; Radiopharmaceuticals; Samarium; Strontium Radioisotopes | 2016 |
Clinical dosimetry in the treatment of bone tumors: old and new agents.
Topics: Bone Neoplasms; Humans; Pain; Palliative Care; Phosphorus Radioisotopes; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radium; Rhenium; Samarium; Strontium Radioisotopes; Tin Radioisotopes | 2011 |
Radioisotopes for metastatic bone pain.
Topics: Bone Neoplasms; Fractures, Bone; Humans; Hypercalcemia; Pain; Pain Measurement; Phosphorus Radioisotopes; Radioisotopes; Randomized Controlled Trials as Topic; Ruthenium Radioisotopes; Samarium; Spinal Cord Compression; Strontium Radioisotopes | 2011 |
Radioisotope therapy of bone metastases.
Topics: Bone Neoplasms; Bone Remodeling; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Pain Management; Patient Selection; Positron-Emission Tomography; Radioisotopes; Samarium; Strontium Radioisotopes; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Use of radionuclides in metastatic prostate cancer: pain relief and beyond.
Topics: Bone Neoplasms; Humans; Male; Men's Health; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radium; Rhenium; Samarium; Strontium | 2012 |
Bone-targeted agents: preventing skeletal complications in prostate cancer.
Topics: Androgen Antagonists; Antibodies, Monoclonal, Humanized; Bone Density; Bone Neoplasms; Clinical Trials as Topic; Clodronic Acid; Denosumab; Diphosphonates; Fractures, Spontaneous; Humans; Imidazoles; Male; Osteoclasts; Osteoporosis; Pamidronate; Prostatic Neoplasms; Quality of Life; Samarium; Toremifene; Zoledronic Acid | 2012 |
Targeted "bone-seeking" radiopharmaceuticals for palliative treatment of bone metastases: a systematic review and meta-analysis.
Topics: Bone Neoplasms; Comorbidity; Humans; Pain; Palliative Care; Radiation Injuries; Radiopharmaceuticals; Risk Factors; Samarium; Strontium Radioisotopes; Treatment Outcome | 2012 |
[Metabolic radiotherapy: what role will it have in 2001?].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Analgesics, Opioid; Bone Neoplasms; Clinical Trials as Topic; Double-Blind Method; Forecasting; France; Hematologic Diseases; Humans; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Phosphorus Radioisotopes; Prospective Studies; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium; Samarium; Strontium; Strontium Radioisotopes; Treatment Outcome | 2002 |
[Palliative treatment of metastasic bone pain].
Topics: Analgesia; Bone Neoplasms; Contraindications; Drug Costs; Forecasting; Humans; Pain; Palliative Care; Radioisotopes; Radiopharmaceuticals; Rhenium; Samarium; Strontium Radioisotopes; Tin Radioisotopes; Treatment Outcome | 2003 |
[Radionuclide therapy for painful bone metastases].
Topics: Bone Neoplasms; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Radioisotopes; Radiopharmaceuticals; Samarium; Strontium; Strontium Radioisotopes | 2004 |
[Standards and Options for the use of radiation therapy in the management of patients with osteosarcoma. Update 2004].
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Humans; Lung; Lung Neoplasms; Meta-Analysis as Topic; Middle Aged; Osteosarcoma; Prospective Studies; Quality of Health Care; Radioisotopes; Radiotherapy Dosage; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Retrospective Studies; Samarium; Time Factors; Treatment Outcome | 2005 |
Radioisotopes for the palliation of metastatic bone cancer: a systematic review.
Topics: Bone Neoplasms; Humans; Neoplasm Metastasis; Pain, Intractable; Palliative Care; Radiography; Radioisotopes; Radiotherapy Dosage; Rhenium; Samarium; Strontium Radioisotopes | 2005 |
Samarium for osteoblastic bone metastases and osteosarcoma.
Topics: Animals; Bone Neoplasms; Drug and Narcotic Control; Drug Tolerance; Humans; Organometallic Compounds; Organophosphorus Compounds; Osteosarcoma; Samarium | 2006 |
The management of painful bone metastases with an emphasis on radionuclide therapy.
Topics: Bone Neoplasms; Combined Modality Therapy; Humans; Neoplasm Metastasis; Pain; Palliative Care; Radioisotopes; Rhenium; Samarium; Strontium Radioisotopes | 2007 |
Samarium lexidronam (153Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma.
Topics: Analgesics, Non-Narcotic; Animals; Bone Neoplasms; Humans; Organometallic Compounds; Organophosphorus Compounds; Osteosarcoma; Radioisotopes; Samarium | 2007 |
Targeted radionuclide therapy for bone metastases.
Topics: Analgesics; Bone Neoplasms; Combined Modality Therapy; Etidronic Acid; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain, Intractable; Palliative Care; Radioisotopes; Radiotherapy; Rhenium; Samarium; Strontium Radioisotopes | 1993 |
Radiopharmaceuticals in clinical trials.
Topics: Animals; Bone Neoplasms; Clinical Trials as Topic; Humans; Palliative Care; Phosphorus Radioisotopes; Radioisotopes; Rhenium; Samarium; Strontium Radioisotopes; Tin Radioisotopes | 1993 |
Systemic administration of new therapeutic radioisotopes, including phosphorus, strontium, samarium, and rhenium.
Topics: Bone Neoplasms; Humans; Phosphorus Radioisotopes; Radioisotopes; Rhenium; Samarium; Strontium Radioisotopes | 1994 |
Radionuclide therapy in oncology.
Topics: 3-Iodobenzylguanidine; Antibodies, Monoclonal; Bone Neoplasms; Brachytherapy; Humans; Iodine Radioisotopes; Iodobenzenes; Neoplasms; Phosphorus Radioisotopes; Radioisotopes; Radiotherapy Dosage; Rhenium; Samarium; Strontium Radioisotopes; Thyroid Neoplasms | 1994 |
Cancer therapy using bone-seeking isotopes.
Topics: Bone Neoplasms; Humans; Neoplasms; Palliative Care; Phosphorus Radioisotopes; Radioisotopes; Radiotherapy Dosage; Rhenium; Samarium; Strontium; Tin Radioisotopes | 1996 |
Radiolabeled bone-seeking radiopharmaceuticals.
Topics: Animals; Bone Neoplasms; Etidronic Acid; Female; Humans; Male; Pentetic Acid; Radioisotopes; Radiopharmaceuticals; Rhenium; Samarium; Tin | 1996 |
How can we improve the treatment of bone metastases further?
Topics: Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Estrogen Antagonists; Female; Forecasting; Humans; Male; Multiple Myeloma; Osteolysis; Osteoporosis; Pain; Palliative Care; Prostatic Neoplasms; Quality of Life; Radioisotope Teletherapy; Randomized Controlled Trials as Topic; Samarium | 1998 |
Samarium Sm-153 lexidronam for the palliation of bone pain associated with metastases.
Topics: Bone Neoplasms; Clinical Trials as Topic; Humans; Pain Management; Palliative Care; Samarium | 2000 |
Therapy of metastatic bone pain.
Topics: Analgesics; Animals; Bone Neoplasms; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain; Phosphates; Phosphorus Radioisotopes; Radioisotopes; Radiopharmaceuticals; Samarium; Strontium; Strontium Radioisotopes | 2001 |
Systemic metabolic radiotherapy with samarium-153 EDTMP for the treatment of painful bone metastasis.
Topics: Analgesics, Non-Narcotic; Animals; Bone Neoplasms; Dogs; Female; Humans; Male; Organometallic Compounds; Organophosphorus Compounds; Pain, Intractable; Palliative Care; Rats; Samarium | 2001 |
Hormone refractory prostatic cancer: the role of radiolabelled diphosphonates and growth factor inhibitors.
Topics: Animals; Bone Neoplasms; Dogs; Drug Screening Assays, Antitumor; Etidronic Acid; Growth Substances; Humans; Male; Neoplasm Proteins; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Samarium; Suramin | 1992 |
15 trial(s) available for samarium and Bone Cancer
Article | Year |
---|---|
A prospective randomized trial: a comparison of the analgesic effect and toxicity of 153Sm radioisotope treatment in monotherapy and combined therapy including local external beam radiotherapy (EBRT) among metastatic castrate resistance prostate cancer (m
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Combined Modality Therapy; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Organophosphorus Compounds; Pain Measurement; Prognosis; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Samarium | 2013 |
Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer.
Topics: Aged; Aged, 80 and over; Bone Diseases; Bone Neoplasms; Double-Blind Method; Drug Combinations; Humans; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain; Pain Measurement; Prospective Studies; Prostatic Neoplasms; Radioisotopes; Samarium | 2004 |
[Cost-effectiveness analysis of samario-153 (Quadramet) for the treatment of patients with prostate cancer and bone metastases].
Topics: Adenocarcinoma; Analgesics, Non-Narcotic; Bone Neoplasms; Cost-Benefit Analysis; Drug Costs; Humans; Male; Models, Economic; Organometallic Compounds; Organophosphorus Compounds; Pain Measurement; Prostatic Neoplasms; Radioisotopes; Samarium; Treatment Outcome | 2005 |
Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases.
Topics: Bone and Bones; Bone Marrow; Bone Neoplasms; Chelating Agents; Humans; Organophosphorus Compounds; Pain; Palliative Care; Radioisotopes; Radionuclide Imaging; Radiotherapy Dosage; Samarium | 1994 |
[The value of Sm-153-EDTMP for treatment of metastatic bone pain and improving quality of life].
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Chelating Agents; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organophosphorus Compounds; Pain, Intractable; Palliative Care; Quality of Life; Radioisotopes; Samarium | 1994 |
Samarium-153-EDTMP in bone metastases.
Topics: Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Organotechnetium Compounds; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Samarium | 1994 |
Samarium-153-EDTMP biodistribution and dosimetry estimation.
Topics: Bone Neoplasms; Chelating Agents; Humans; Male; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiotherapy Dosage; Samarium; Technetium Tc 99m Medronate; Tissue Distribution | 1993 |
Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Hormones; Humans; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain Measurement; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiotherapy Dosage; Samarium | 1993 |
Dose response relationship and multiple dose efficacy and toxicity of samarium-153-EDTMP in metastatic cancer to bone.
Topics: Bone Neoplasms; Dose-Response Relationship, Radiation; Humans; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain; Pain Management; Palliative Care; Radioisotopes; Radiotherapy Dosage; Samarium | 1997 |
A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Bone Neoplasms; Dose-Response Relationship, Radiation; Female; Follow-Up Studies; Humans; Leukocyte Count; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Platelet Count; Radioisotopes; Radionuclide Imaging; Samarium; Survival Rate; Treatment Outcome | 1997 |
Multicentre trial on the efficacy and toxicity of single-dose samarium-153-ethylene diamine tetramethylene phosphonate as a palliative treatment for painful skeletal metastases in China.
Topics: Analgesics, Non-Narcotic; Bone Neoplasms; China; Dose-Response Relationship, Radiation; Female; Humans; Karnofsky Performance Status; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Radioisotopes; Radiotherapy Dosage; Samarium | 1999 |
Prospective 153Sm-EDTMP therapy dosimetry by whole-body scintigraphy.
Topics: Bone Neoplasms; Breast Neoplasms; Disease Progression; Female; Humans; Male; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Pancreatic Neoplasms; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy Dosage; Samarium; Tomography, Emission-Computed | 1999 |
Samarium Sm-153 lexidronam for the palliation of bone pain associated with metastases.
Topics: Bone Neoplasms; Clinical Trials as Topic; Humans; Pain Management; Palliative Care; Samarium | 2000 |
Strontium and samarium therapy for bone metastases from prostate carcinoma.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Humans; Male; Middle Aged; Prostatic Neoplasms; Radioisotopes; Retrospective Studies; Samarium; Strontium; Strontium Radioisotopes | 1999 |
Hormone refractory prostatic cancer: the role of radiolabelled diphosphonates and growth factor inhibitors.
Topics: Animals; Bone Neoplasms; Dogs; Drug Screening Assays, Antitumor; Etidronic Acid; Growth Substances; Humans; Male; Neoplasm Proteins; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Samarium; Suramin | 1992 |
66 other study(ies) available for samarium and Bone Cancer
Article | Year |
---|---|
Europium radionuclides in samarium-153-Ethylene Diamine Tetramethylene phosphonic acid (
Topics: Bone Neoplasms; Ethylenes; Europium; Humans; Organometallic Compounds; Organophosphorus Compounds; Phosphorous Acids; Radioactive Waste; Radioisotopes; Radiopharmaceuticals; Samarium | 2022 |
Efficacy and safety of
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Humans; Male; Middle Aged; Pain; Radioisotopes; Retrospective Studies; Samarium; Treatment Outcome | 2018 |
An electrochemical approach for removal of radionuclidic contaminants of Eu from
Topics: Animals; Bone Neoplasms; Cancer Pain; Electrochemistry; Europium; Feasibility Studies; Organophosphonates; Palliative Care; Radiochemistry; Radioisotopes; Rats; Rats, Wistar; Samarium | 2018 |
EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides.
Topics: Bone Neoplasms; Humans; Male; Organometallic Compounds; Organophosphorus Compounds; Prostatic Neoplasms; Quality of Life; Radioisotopes; Samarium; Strontium Radioisotopes | 2018 |
Synthesis and characterization of calcium phosphate loaded with Ho-166 and Sm-153: a novel biomaterial for treatment of spine metastases.
Topics: Biocompatible Materials; Bone Cements; Bone Neoplasms; Calcium Phosphates; Ceramics; Drug Delivery Systems; Gamma Rays; Holmium; Humans; Neoplasm Metastasis; Neutrons; Phase Transition; Powders; Radioisotopes; Samarium; Spine; Temperature | 2013 |
Palliative treatment of bone metastases with samarium-153 EDTMP at onset of pain.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Female; Humans; Male; Middle Aged; Pain; Palliative Care; Samarium | 2014 |
Comparative analysis of 11 different radioisotopes for palliative treatment of bone metastases by computational methods.
Topics: Algorithms; Beta Particles; Bone Neoplasms; Computer Simulation; DNA; DNA Damage; DNA Repair; Humans; Lutetium; Monte Carlo Method; Neoplasm Metastasis; Palliative Care; Radioisotopes; Radiopharmaceuticals; Radium; Rhenium; Samarium; Strontium Radioisotopes | 2014 |
Society for palliative radiation oncology: report from the Third Annual Meeting (2016).
Topics: Bone Neoplasms; Congresses as Topic; Humans; Palliative Medicine; Practice Guidelines as Topic; Radiation Oncology; Radioisotopes; Radiopharmaceuticals; Samarium; Societies, Medical; Spinal Neoplasms | 2017 |
Radiation safety considerations for the bone seeking radiopharmaceuticals. 89SrCl2, 186Re-HEDP and 153Sm-EDTMP.
Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Organophosphorus Compounds; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Rhenium; Safety; Samarium; Strontium; Strontium Radioisotopes | 2009 |
Comparison of systemic toxicities of 177Lu-DOTMP and 153Sm-EDTMP administered intravenously at equivalent skeletal doses to normal dogs.
Topics: Animals; Blood Cell Count; Bone Marrow; Bone Neoplasms; Dogs; Female; Lutetium; Male; Organometallic Compounds; Organophosphorus Compounds; Radiation Dosage; Radioisotopes; Samarium | 2009 |
[Bone targeting of antitumor conjugate phenamine acid aryolysine-hexanedioic acid bridge grafting-bisphosphonates].
Topics: Acrylates; Adipates; Amphetamine; Bone Neoplasms; Diphosphonates; Drug Delivery Systems; Humans; Nitrogen Mustard Compounds; Radioisotopes; Samarium | 2009 |
Optimal treatment of painful bone metastases with Samarium EDTMP in a haemodialysis patient: effectiveness and safety of internal radiotherapy.
Topics: Aged; Analgesics, Non-Narcotic; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Organometallic Compounds; Organophosphorus Compounds; Renal Dialysis; Samarium | 2009 |
Background, reasons and benefits using the vienna protocol for the treatment of painful bone recurrences with 153Samarium-EDTMP.
Topics: Analgesics, Non-Narcotic; Bone Neoplasms; Humans; Neoplasm Recurrence, Local; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Samarium; Treatment Outcome | 2009 |
Samarium-153 treatment of bone pain in patients with metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Humans; Male; Pain; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radioisotopes; Samarium | 2010 |
153Sm-EDTMP and (89)SrCl(2) in a dog with spontaneous osteosarcoma.
Topics: Animals; Autoradiography; Bone Neoplasms; Dog Diseases; Dogs; Humans; Organometallic Compounds; Organophosphorus Compounds; Osteosarcoma; Radionuclide Imaging; Samarium; Strontium | 2002 |
[Myelotoxicity after systemic radionuclide therapy of painful bone metastases with 153Samarium-EDTMP ].
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Female; Humans; Infusions, Intravenous; Kidney Neoplasms; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain, Intractable; Palliative Care; Pancytopenia; Prostatic Neoplasms; Radiopharmaceuticals; Samarium | 2003 |
Gemcitabine radiosensitization after high-dose samarium for osteoblastic osteosarcoma.
Topics: Adolescent; Adult; Alkaline Phosphatase; Analgesics, Non-Narcotic; Antigens, CD34; Bone and Bones; Bone Neoplasms; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Humans; Image Processing, Computer-Assisted; Neoplasm Metastasis; Organometallic Compounds; Organophosphorus Compounds; Osteosarcoma; Pain; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Remission Induction; Samarium; Sarcoma; Stem Cells; Time Factors | 2005 |
[Primary investigation of dose-effect relationship of 153Sm-EDTMP in treating multiple bone metastases].
Topics: Adult; Analgesics, Non-Narcotic; Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Radiation; Female; Humans; Middle Aged; Monte Carlo Method; Nasopharyngeal Neoplasms; Organometallic Compounds; Organophosphorus Compounds; Pain; Pain Measurement; Radioisotopes; Samarium | 2006 |
[Three-dimensional dose calculation of 153Sm-EDTMP in treating bone metastasis--comparison of Monte Carlo and S value calculation methods].
Topics: Bone Neoplasms; Humans; Imaging, Three-Dimensional; Monte Carlo Method; Organometallic Compounds; Organophosphorus Compounds; Radioisotopes; Radiotherapy Dosage; Samarium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2006 |
Safety and efficacy of repeat administration of samarium Sm-153 lexidronam to patients with metastatic bone pain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Bone Neoplasms; Breast Neoplasms; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain; Pain Measurement; Palliative Care; Prospective Studies; Prostatic Neoplasms; Safety; Samarium | 2007 |
Prospective evaluation of samarium-153-EDTMP radionuclide treatment for bone metastases in patients with hormone-refractory prostate cancer.
Topics: Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Bone Neoplasms; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain; Pain Measurement; Prospective Studies; Prostatic Neoplasms; Radionuclide Imaging; Samarium; Treatment Outcome | 2007 |
Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Combined Modality Therapy; Diphosphonates; Humans; Imidazoles; Injections, Intravenous; Male; Metabolic Clearance Rate; Neoplasm Metastasis; Organometallic Compounds; Organophosphorus Compounds; Prostatic Neoplasms; Radioisotopes; Samarium; Zoledronic Acid | 2008 |
Safety analysis of repeated high doses of samarium-153 lexidronam in men with hormone-naive prostate cancer metastatic to bone.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Bone Neoplasms; Dose-Response Relationship, Drug; Feasibility Studies; Humans; Male; Middle Aged; Neoplasms, Hormone-Dependent; Organometallic Compounds; Organophosphorus Compounds; Prostatic Neoplasms; Samarium; Survival Rate | 2008 |
Studies on incorporated short-lived beta-emitters with regard to the induction of late effects.
Topics: Animals; Bone Neoplasms; Dose-Response Relationship, Radiation; Female; Liver; Lutetium; Mice; Neoplasms, Radiation-Induced; Osteosarcoma; Radioisotopes; Samarium; Time Factors | 1980 |
[Effect of 153Sm-EDTMP on hematopoiesis and vital organs of 93 patients with bone tumor].
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Hematopoiesis; Humans; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Organometallic Compounds; Organophosphorus Compounds; Platelet Count; Radioisotopes; Samarium | 1995 |
Pain palliation and nuclear medicine.
Topics: Bone Neoplasms; Etidronic Acid; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain, Intractable; Palliative Care; Radioisotopes; Rhenium; Samarium; Strontium Radioisotopes | 1993 |
Pronounced therapeutic effect of samarium 153-ethylenediaminetetramethylene phosphonate in an orthotopic human osteosarcoma tibial tumor model.
Topics: Animals; Bone Neoplasms; Disease Models, Animal; Dose-Response Relationship, Radiation; Humans; Neoplasm Transplantation; Organometallic Compounds; Organophosphorus Compounds; Osteosarcoma; Radioisotopes; Radiotherapy Dosage; Rats; Rats, Nude; Samarium; Tibia | 1995 |
Analysis of urine samples from metastatic bone cancer patients administered 153Sm-EDTMP.
Topics: Bone Neoplasms; Chelating Agents; Chromatography, High Pressure Liquid; Humans; Organophosphorus Compounds; Pain; Radioisotopes; Samarium | 1993 |
[153Sm-EDTMP for moderate and severe bone cancer pain].
Topics: Adult; Aged; Analgesics, Non-Narcotic; Bone Neoplasms; Breast Neoplasms; Female; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain, Intractable; Radioisotopes; Samarium | 1995 |
Biospeciation, by potentiometry and computer simulation, of Sm-EDTMP, a bone tumor palliative agent.
Topics: Bone Neoplasms; Computer Simulation; Humans; In Vitro Techniques; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Plasma; Potentiometry; Protons; Radioisotopes; Samarium | 1996 |
Samarium-153 lexidronam for painful bone metastases.
Topics: Analgesics, Non-Narcotic; Bone Neoplasms; Clinical Trials as Topic; Costs and Cost Analysis; Dose-Response Relationship, Drug; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Radioisotopes; Samarium | 1997 |
New research developments increase therapeutic options for thyroid cancer and bone pain palliation.
Topics: Analgesics, Non-Narcotic; Bone Neoplasms; Female; Humans; Iodine Radioisotopes; Isotopes; Male; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Pentetic Acid; Radioisotopes; Recombinant Proteins; Samarium; Strontium; Strontium Radioisotopes; Thyroid Neoplasms; Thyrotropin; Tin | 1997 |
Predicting detectability in radioguided surgery: a study based on physical characterization of the probe and on tissue uptake ratios of 125I-, 153Sm- and 165Er-labelled radiopharmaceuticals.
Topics: Animals; Biological Transport; Bone Neoplasms; Female; Humans; Iodine Radioisotopes; Lung Neoplasms; Mice; Mice, Inbred BALB C; Models, Biological; Organometallic Compounds; Organophosphorus Compounds; Predictive Value of Tests; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radiosurgery; Samarium; Sensitivity and Specificity; Tissue Distribution | 1998 |
Targeted radiotherapy with Sm-153-EDTMP in nine cases of canine primary bone tumours.
Topics: Age Factors; Analgesics, Non-Narcotic; Animals; Body Weight; Bone Neoplasms; Dog Diseases; Dogs; Female; Male; Organometallic Compounds; Organophosphorus Compounds; Osteosarcoma; Pain; Radiography, Thoracic; Radioisotopes; Samarium; Sex Factors; Treatment Outcome | 1998 |
Quantifying the radiation dosage to individual skeletal lesions treated with samarium-153-EDTMP.
Topics: Autoradiography; Bone Neoplasms; Gamma Cameras; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain; Phantoms, Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Samarium; Tissue Distribution; Tomography, Emission-Computed | 1998 |
Variation in oncologic opinion regarding management of metastatic bone pain with systemic radionuclide therapy.
Topics: Aged; Analgesics, Opioid; Attitude of Health Personnel; Bone Neoplasms; Data Collection; Female; Humans; Male; Medical Oncology; Middle Aged; Pain; Palliative Care; Radioisotopes; Samarium; Strontium Radioisotopes | 1999 |
Internal radionuclide therapy of primary osteosarcoma in dogs, using 153Sm-ethylene-diamino-tetramethylene-phosphonate (EDTMP).
Topics: Animals; Bone Neoplasms; Brachytherapy; Dogs; Female; Male; Neoplasm Metastasis; Organophosphonates; Osteosarcoma; Radiotherapy Dosage; Samarium | 1999 |
High-activity samarium-153-EDTMP therapy in unresectable osteosarcoma.
Topics: Adult; Bone Neoplasms; Female; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Organometallic Compounds; Organophosphorus Compounds; Osteosarcoma; Pain; Palliative Care; Pelvic Neoplasms; Radioisotopes; Radionuclide Imaging; Samarium | 1999 |
Radionuclides for metastatic bone pain palliation: a need for rational re-evaluation in the new millennium.
Topics: Analgesics, Non-Narcotic; Animals; Bone Neoplasms; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain, Intractable; Palliative Care; Phosphorus Radioisotopes; Radioisotopes; Samarium; Strontium; Strontium Radioisotopes | 2000 |
[Inhibitory effect of samarium-153-labeled ethylenediaminetetramethylene phosphonate (EDTMP) on bone invasion and osteolysis in Walker 256 carcinoma bearing rats].
Topics: Animals; Bone Neoplasms; Carcinoma 256, Walker; Male; Neoplasm Invasiveness; Organometallic Compounds; Organophosphorus Compounds; Osteolysis; Radioisotopes; Rats; Samarium; Tibia | 1997 |
Successful use of Samarium 153 for emergency treatment of disseminated intravascular coagulation due to metastatic hormone refractory prostate cancer.
Topics: Antineoplastic Agents, Hormonal; Bone Neoplasms; Disseminated Intravascular Coagulation; Gingival Hemorrhage; Hematoma; Hemostatic Techniques; Humans; Injections, Intravenous; Male; Middle Aged; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Samarium | 2000 |
Metal-ion speciation in blood plasma incorporating the tetraphosphonate, N,N-dimethylenephosphonate-1-hydroxy-4-aminopropilydenediphosphonate (APDDMP), in therapeutic radiopharmaceuticals.
Topics: Analgesics, Non-Narcotic; Animals; Bone and Bones; Bone Neoplasms; Diphosphonates; Holmium; Humans; Ligands; Models, Biological; Papio; Protons; Radioisotopes; Radiopharmaceuticals; Samarium | 2001 |
ESR dosimetry of 89Sr and 153Sm in bone.
Topics: Animals; Bone and Bones; Bone Marrow; Bone Neoplasms; Electron Spin Resonance Spectroscopy; Humans; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Rabbits; Radioisotopes; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Samarium; Strontium; Strontium Radioisotopes | 2001 |
Skeletal uptake and soft-tissue retention of 186Re-HEDP and 153Sm-EDTMP in patients with metastatic bone disease.
Topics: Aged; Bone and Bones; Bone Neoplasms; Etidronic Acid; Female; Humans; Male; Middle Aged; Muscle, Skeletal; Organometallic Compounds; Organophosphorus Compounds; Pain Management; Palliative Care; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Samarium; Thigh; Urinary Bladder | 2001 |
Hemodialysis in a patient being treated with 153Sm.
Topics: Aged; Bone Neoplasms; Female; Hemodialysis Solutions; Humans; Pain; Palliative Care; Radioisotopes; Renal Dialysis; Samarium | 2001 |
Radionuclide therapy with bone-seeking compounds: Monte Carlo calculations of dose-volume histograms for bone marrow in trabecular bone.
Topics: Age Factors; Bone Neoplasms; Cell Survival; Dose-Response Relationship, Radiation; Hematopoietic Stem Cells; Humans; Isotopes; Models, Theoretical; Monte Carlo Method; Radioisotopes; Radiotherapy Planning, Computer-Assisted; Rhenium; Samarium; Strontium Radioisotopes; Tin | 2001 |
[153Sm-EDTMP in a patient suffering from colon cancer with bone metastasis].
Topics: Adenocarcinoma; Adult; Beta Particles; Bone Neoplasms; Cervical Vertebrae; Gamma Rays; Humans; Male; Organophosphorus Compounds; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rectal Neoplasms; Samarium; Scapula; Skull Neoplasms; Spinal Neoplasms | 2001 |
High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Dose-Response Relationship, Drug; Hematologic Diseases; Humans; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Organophosphorus Compounds; Osteosarcoma; Palliative Care; Radioisotopes; Samarium; Tissue Distribution | 2002 |
Bony metastases seen on scintigraphy with samarium-153.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Humans; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Samarium | 2002 |
High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Female; Humans; Osteosarcoma; Pelvic Bones; Radiopharmaceuticals; Radiotherapy, Adjuvant; Samarium; Treatment Outcome | 2002 |
A method for measurement of the uptake patterns of two beta-emitting radionuclides in the same tissue section with a digital silicon detector: application to a study of 89SrCl2 and 153Sm-EDTMP in a dog with spontaneous osteosarcoma.
Topics: Animals; Autoradiography; Bone Neoplasms; Dog Diseases; Dogs; Organometallic Compounds; Organophosphorus Compounds; Osteosarcoma; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Samarium; Strontium; Strontium Radioisotopes | 2002 |
Complete scintigraphic lesion regression after single 153Sm-EDTMP therapy in prostate cancer.
Topics: Adenocarcinoma; Bone Neoplasms; Humans; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Samarium | 2001 |
[Radioisotopes used in the diagnosis of bone diseases].
Topics: Bone and Bones; Bone Diseases; Bone Neoplasms; Diagnosis, Differential; Humans; Radiation Dosage; Radioisotopes; Radionuclide Imaging; Samarium; Strontium Radioisotopes; Technetium; Ytterbium | 1976 |
Samarium-153-labelled EDTMP for bone metastases from cancer of the prostate.
Topics: Aged; Aged, 80 and over; Bone Marrow; Bone Neoplasms; Carcinoma; Humans; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiotherapy Dosage; Remission Induction; Samarium; Survival Rate; Thrombocytopenia | 1992 |
Clinical and clinicopathologic effects of samarium-153-EDTMP administered intravenously to normal beagle dogs.
Topics: Alkaline Phosphatase; Animals; Bone Marrow; Bone Neoplasms; Dogs; Female; Injections, Intravenous; Leukocyte Count; Male; Organophosphorus Compounds; Radioisotopes; Samarium | 1990 |
Internally administered isotopes in the treatment of solid malignancy.
Topics: Animals; Bone Neoplasms; Dogs; Lung Neoplasms; Microspheres; Organophosphorus Compounds; Phosphorus Radioisotopes; Radioisotopes; Samarium | 1990 |
Clinical and clinicopathologic response of canine bone tumor patients to treatment with samarium-153-EDTMP.
Topics: Animals; Bone Neoplasms; Dog Diseases; Dogs; Drug Administration Schedule; Female; Leukocyte Count; Male; Organophosphorus Compounds; Osteosarcoma; Platelet Count; Radioisotopes; Samarium | 1990 |
Radionuclide targeting of bone metastases: which efficacy?
Topics: Bone Neoplasms; Brachytherapy; Diphosphonates; Humans; Organophosphorus Compounds; Pamidronate; Radioisotopes; Samarium | 1990 |
Human pharmacokinetics of samarium-153 EDTMP in metastatic cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Drug Evaluation; Humans; Male; Middle Aged; Organophosphorus Compounds; Palliative Care; Radioisotopes; Samarium; Tissue Distribution | 1989 |
Samarium-153 EDTMP therapy of disseminated skeletal metastasis.
Topics: Animals; Bone Marrow; Bone Neoplasms; Female; Humans; Male; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Rabbits; Radioisotopes; Radiotherapy Dosage; Rats; Rats, Inbred Strains; Samarium; Sheep; Tissue Distribution | 1989 |
A phase I study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases.
Topics: Bone Neoplasms; Dose-Response Relationship, Radiation; Hematopoiesis; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain; Radioisotopes; Radiotherapy Dosage; Samarium | 1989 |
153Sm-EDTMP and 186Re-HEDP as bone therapeutic radiopharmaceuticals.
Topics: Animals; Bone Neoplasms; Dogs; Etidronic Acid; Humans; Kinetics; Organophosphorus Compounds; Pain; Rabbits; Radioisotopes; Radionuclide Imaging; Rhenium; Samarium; Technetium Tc 99m Medronate; Tissue Distribution | 1987 |
Radiation dose calculations in persons receiving injection of samarium-153 EDTMP.
Topics: Animals; Bone Neoplasms; Chelating Agents; Energy Transfer; Humans; Mathematics; Organophosphorus Compounds; Radiation Dosage; Radioisotopes; Rats; Samarium; Tissue Distribution | 1987 |
153Sm radiotherapeutic bone agents.
Topics: Acetates; Bone Neoplasms; Chromatography, High Pressure Liquid; Humans; Ligands; Radioisotopes; Samarium | 1986 |
Experimental agents for skeletal imaging.
Topics: Barium; Bone Neoplasms; Chelating Agents; Dysprosium; Edetic Acid; Erbium; Female; Fluorides; Half-Life; Humans; Isotope Labeling; Male; Middle Aged; Neoplasm Metastasis; Phosphates; Radiation Dosage; Radioisotopes; Radionuclide Imaging; Samarium; Technetium | 1972 |
157 Dy-HEDTA for skeletal imaging.
Topics: Animals; Bone and Bones; Bone Neoplasms; Dogs; Dysprosium; Edetic Acid; Erbium; Fluorine; Nuclear Physics; Rabbits; Radioisotopes; Radionuclide Imaging; Samarium; Strontium Isotopes; Technetium; Terbium; Tibial Fractures | 1971 |